基本信息
彭华  女  博导  广州国家实验室
电子邮件: hpeng@ibp.ac.cn
通信地址: 北京朝阳区大屯路15号6923房间
邮政编码:

招生信息

   
招生专业
100102-免疫学
招生方向
免疫学,病毒疫苗研发,肿瘤免疫治疗

出版信息

   
发表论文
(1) Engineered anti-PDL1 with IFN�� targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance., Gut, 2023, 
(2) An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis delivery, ournal of Experimental Medicine, 2022, 
(3) A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors., Science Immunology, 2022, 
(4) Non-adjuvanted interferon-armed RBD protein nasal drops protect airway infection from SARS-CoV-2, Cell Discovery, 2022, 
(5) Tumor-conditional IL-15 pro-cytokine reactivates anti-tumor immunity with limited toxicity., Cell Research, 2021, 
(6) Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2., Cell Research, 2021, 
(7) Broad neutralization against SARS-CoV-2 variants induced by a next-generation protein vaccine V-01, Cell Discovery, 2021, 
(8) Targeting tumors with IL-21 reshapes the tumor microenvironment by proliferating PD-1intTim-3-CD8+ T cells, JCI Insight, 2020, 
(9) A next generation tumor-targeting IL-2 preferentially promotes tumor infiltrating CD8+ T cells response and effective tumor control, Nature Communications, 2019, 
(10) PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression, Journal of Clinical Investigation, 2018, 

科研活动

   
科研项目
( 1 ) 水痘-带状疱疹病毒预防性疫苗, 负责人, 境内委托项目, 2024-06--2025-12
( 2 ) HBV治疗性疫苗研发, 负责人, 境内委托项目, 2023-12--2024-12